Is Intuitive Surgical, Inc. (ISRG) A Good Stock To Buy Now?

Is ISRG a bully banal to buy? We came crossed a bullish thesis connected Intuitive Surgical, Inc. connected MTC’s Substack. In this article, we volition summarize the bulls’ thesis connected ISRG. Intuitive Surgical, Inc.'s stock was trading astatine $483.46 arsenic of March 16th. ISRG’s trailing and guardant P/E were 59.99 and 47.39 respectively according to Yahoo Finance.

Master Video/Shutterstock.com

Intuitive Surgical, Inc. (ISRG) stands arsenic a defining unit successful modern aesculapian technology, having pioneered and scaled robotic country into a ascendant planetary level with astir 70% marketplace share, a 12,000-system installed base, and a concern exemplary generating astir 85% recurring revenue. The company’s enactment is anchored successful its da Vinci ecosystem, including the precocious launched da Vinci 5, which delivers step-change improvements successful computing powerfulness and introduces unit feedback technology, alongside established systems similar Xi, X, and SP that service a wide scope of surgical specialties.

Read More: 15 AI Stocks That Are Quietly Making Investors Rich

Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential

Complementing this portfolio is the Ion platform, expanding Intuitive Surgical’s reach into minimally invasive diagnostics, peculiarly lung crab detection. Its razor-and-blade exemplary drives durable economics, with high-margin instruments and accessories contributing the bulk of gross and creating long-term, non-discretionary request tied to process volumes, which exceeded 3 cardinal annually.

The institution operates successful a robotic country marketplace expected to turn from astir $16 cardinal successful 2026 to implicit $50 cardinal by 2035, supported by expanding adoption crossed wide country and planetary markets, wherever penetration remains comparatively low. While Intuitive Surgical has already achieved meaningful penetration successful urology and gynecology, important whitespace remains, peculiarly successful wide surgery, representing a important measurement enlargement opportunity.

Its competitory presumption is reinforced by precocious switching costs, heavy surgeon grooming integration, a immense patent portfolio, and a almighty information moat built connected millions of procedures, enabling continuous innovation and AI-driven advancements. Although contention from players similar Medtronic and Johnson & Johnson is intensifying, Intuitive Surgical’s entrenched ecosystem, standard advantages, and proven objective outcomes presumption it to prolong enactment and seizure a disproportionate stock of this expanding market, offering a compelling semipermanent maturation and rerating opportunity.